1. Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial. Issue 10191 (29th June 2019) Authors: Al-Shahi Salman, Rustam; Dennis, MS; Sandercock, PAG; Sudlow, CLM; Wardlaw, JM; Whiteley, WN; Murray, GD; Stephen, J; Newby, DE; Sprigg, N; Werring, DJ; White, PM; Baigent, Colin; Lasserson, Daniel; Sullivan, Frank; Carrie, Johanna; Rojas, Javier; Amoils, Shannon; Bamford, John; Armitage, Jane Journal: Lancet Issue: Volume 393:Issue 10191(2019) Page Start: 2613 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial. Issue 10168 (19th January 2019) Authors: Dennis, Martin; Mead, Gillian; Forbes, John; Graham, Catriona; Hackett, Maree; Hankey, Graeme J; House, Allan; Lewis, Stephanie; Lundström, Erik; Sandercock, Peter; Innes, Karen; Williams, Carol; Drever, Jonathan; Mcgrath, Aileen; Deary, Ann; Fraser, Ruth; Anderson, Rosemary; Walker, Pauli; Perry... Journal: Lancet Issue: Volume 393:Issue 10168(2019) Page Start: 265 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Exenatide once weekly over 2 years as a potential disease-modifying treatment for Parkinson's disease: protocol for a multicentre, randomised, double blind, parallel group, placebo controlled, phase 3 trial: The 'Exenatide-PD3' study. Issue 5 (28th May 2021) Authors: Vijiaratnam, Nirosen; Girges, Christine; Auld, Grace; Chau, Marisa; Maclagan, Kate; King, Alexa; Skene, Simon; Chowdhury, Kashfia; Hibbert, Steve; Morris, Huw; Limousin, Patricia; Athauda, Dilan; Carroll, Camille B; Hu, Michele T; Silverdale, Monty; Duncan, Gordon W; Chaudhuri, Ray; Lo, Christine... Journal: BMJ open Issue: Volume 11:Issue 5(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗